Lecanemab (Leqembi): What It Really Does for Alzheimer's

Most families hear "Leqembi" from a neurologist and go home to spend hours reading studies and forum posts — and end up more confused than when they started. That's not a failure to understand. It's a failure of explanation.In this episode, neurology nurse practitioner Rosabel Zohfeld breaks down what lecanemab (Leqembi) actually does inside the brain, the real Clarity AD trial data (not the headlines), who qualifies, what the risks really are — including ARIA and APOE4 status — and why the window for this treatment to help doesn't stay open forever.You'll learn:• What lecanemab does at the cellular level, and what it can't do• The real numbers behind the "27% slower decline" headline• Who qualifies for treatment — and who doesn't• The truth about ARIA, APOE4 genotyping, and monitoring• A clear framework to bring to your own neurology appointmentFree resource: Understanding Dementia Guide — the full landscape of Alzheimer's care, staging, and what to expect, in plain language.👉 https://rosabelzohfeld.com/understanding-dementia/I'm Rosabel Zohfeld — Neurology Nurse Practitioner & Neuroscience Educator. Real neuroscience. No toxic positivity. No jargon.🔗 Free resources: https://rosabelzohfeld.com/rosabelievers/🌎 Website: https://rosabelzohfeld.com📸 Instagram: @rosabelunscripted🎵 TikTok: @rosabelzoh🎧 Follow so you don't miss next week's episode.